Firm News: Drugs & Devices: Page 7

W&L Applauds FDA Safety Concerns for Surgical Mesh in Vaginal Repair

On January 4, the U.S. Food and Drug Administration (FDA) strengthened requirements governing surgical mesh for the transvaginal repair of pelvic organ prolapse (POP). W&L hails this action as vital to addressing safety risks posed by transvaginal mesh devices. “Previously, transvaginal mesh products were classified as Class II moderate-risk medical devices, but the FDA has…

W&L Taking OMNIlife Science Apex K2 Modular Hip System Injury Cases

Weitz & Luxenberg, P.C., is now accepting cases involving total hip arthroplasty patients who have been implanted with an OMNIlife science Apex K2 Modular Hip System hip implant. W&L began investigating these cases after reports of patient injuries appeared in medical journals. There was also a reported rate of revision in the Australian Orthopaedic Association…

Get the Help You Need Today

Free Case Review